knowledge -WSS

knowledge

author：comprehensive 2025-09-29 18:15:50 - browse：5758

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： 'Essentially witchcraft:' A former naturopath takes on the field

focus

WSS

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Readers discuss the intersection of pregnancy and addiction

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Study: Why relieving medical debt did not improve financial outcomes

After gene therapy, two congenitally deaf children hear for the first time

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

hotspot

knowledge

entertainment

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Dobbs anniversary: the lost opportunity of abortion as health care

Steward Health Care files for bankruptcy

Cancer drug shortages should be causing more outrage

How to improve immunocompromised access to mAb treatments

Medicare details structure of new drug price negotiation program

STAT Virtual Event: ASCO Recap, Live!

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cigna wins case to block Amy Bricker's move to CVS

focus

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Google says AlphaFold 3 can map a vast universe of biomolecules

Cigna wins case to block Amy Bricker's move to CVS

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Sanofi strikes deal with Novavax, boosting the vaccine maker

explore

focus

focus

knowledge